MTOR and non-small cell lung carcinoma: Simultaneously, GYZ stimulated cytoprotective autophagy in NSCLC cells through suppression of the Akt/mTOR signaling pathway and co-treatment with autophagy inhibitors obviously enhanced the anti-NSCLC effects of GYZ.